Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

695.20
+6.320.92%
Number of Gainers:83
Number of Losers:58
Number of Flat:13
PE:- -
High:698.21
Open:689.82
Low:685.07
Close:688.92
Volume:124.59M
Turnover:4.65B
Market Cap:481.08B
Float Cap:366.17B

Loading ...

Option Focus | Robinhood's $2.69 Million Long-Dated Put Buy and Bear Call Spread Signal Institutional Caution as Upside Appears Capped

Option Witch
·
Sep 05

Defence Therapeutics Details First Settlement Under Sorbie Sharing Agreement

TIPRANKS
·
Sep 05

Coinbase adds six tokenized stocks after $228M debut

cryptonews
·
Sep 05

NYSE Net Change Percentage Gainers & Losers

Dow Jones
·
Sep 05

EverCommerce Director Eric Richard Remer Sells USD 118,562 of Common Shares

Reuters
·
Sep 05

Robinhood Stock: Why Football Season Could Matter More Than Crypto

TIPRANKS
·
Sep 05

Rein Therapeutics Highlights LTI-03 Progress in IPF

TIPRANKS
·
Sep 05

iSpecimen Announces Special Shareholder Meeting

Reuters
·
Sep 05

Robinhood Chief Legal Officer Daniel M. Gallagher Jr Sells USD 1.45 Million in Common Shares

Reuters
·
Sep 05

LifeStance Health CTO Vukasin Paunovich Sells 42,067 Shares for $541,202.29

Reuters
·
Sep 05

iSpecimen - Enters Asset Purchase Agreement with Foldlab AI on Sept 4, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 05

iSpecimen - to Buy AI Software and Models Including Disease Trend Prediction AI Model - SEC Filing

THOMSON REUTERS
·
Sep 05

iSpecimen - Deal Valued at $4.50 Mln: $2 Mln Cash, $2.50 Mln in Common Stock - SEC Filing

THOMSON REUTERS
·
Sep 05

iSpecimen to Buy Foldlab AI Software Assets for $4.5 Million Cash and Stock

Reuters
·
Sep 05

Kanzhun Reports August Share Movements and Confirms Public Float Compliance

TIPRANKS
·
Sep 05

Robinhood-AMC clash may speed US stock token rules

cryptonews
·
Sep 05

Riskified CTO Shauli Avi Sells 30,000 Shares for $193,065

Reuters
·
Sep 05

Vera Therapeutics CEO Fordyce Marshall Disposes of USD 649,642 Common Shares

Reuters
·
Sep 05

Clear Street transfers coverage on Molecular Partners, keeps Buy rating

TIPRANKS
·
Sep 05

Alzamend Neuro Inc Expected to Post a Loss of 56 Cents a Share - Earnings Preview

Reuters
·
Sep 05